Annual report pursuant to Section 13 and 15(d)

Segment Information - Summary of Reportable Segments (Detail)

v3.24.1
Segment Information - Summary of Reportable Segments (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]    
Revenues $ 159,237 $ 163,213
Gross profit (loss) 63,169 74,432
Depreciation and amortization 25,143 29,095
(Recoveries), write-downs and other charges, net 410 (846)
Impairment loss 0 30,551
Net (loss) income (76,621) (449,391)
Purchase of property, plant and equipment 3,572 6,939
Purchase of intangibles assets 2,504 113
Assets 277,407 303,467
Eastern Region    
Segment Reporting Information [Line Items]    
Revenues 105,922 96,478
Gross profit (loss) 43,839 52,108
Depreciation and amortization 17,306 16,743
(Recoveries), write-downs and other charges, net 42 (620)
Impairment loss 0 695
Net (loss) income (29,332) (4,981)
Purchase of property, plant and equipment 3,373 5,954
Purchase of intangibles assets 2,489 0
Assets 215,743 226,458
Western Region    
Segment Reporting Information [Line Items]    
Revenues 53,088 65,644
Gross profit (loss) 19,609 21,910
Depreciation and amortization 7,339 11,820
(Recoveries), write-downs and other charges, net (4) 0
Impairment loss 0 29,856
Net (loss) income (3,200) (38,019)
Purchase of property, plant and equipment 192 982
Purchase of intangibles assets 0 0
Assets 51,148 60,896
Other    
Segment Reporting Information [Line Items]    
Revenues [1] 227 1,091
Gross profit (loss) (279) 414
Depreciation and amortization 498 532
(Recoveries), write-downs and other charges, net 372 (226)
Impairment loss 0 0
Net (loss) income (44,089) (406,391)
Purchase of property, plant and equipment 7 3
Purchase of intangibles assets 15 113
Assets $ 10,516 $ 16,113
[1] Revenues from segments below the quantitative thresholds are attributable to an operating segment of the Company that includes revenue from the sale of CBD products throughout the United States. This segment has never met any of the quantitative thresholds for determining reportable segments nor does it meet the qualitative criteria for aggregation with the Company’s reportable segments. The Company has deconsolidated results from its Vermont and CBD operations as of March 8, 2023 and May 8, 2023, respectively.